OTCMKTS:WUXAY WuXi AppTec (WUXAY) Stock Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free WUXAY Stock Alerts $4.48 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$4.48▼$4.4850-Day Range$4.10▼$6.9252-Week Range$4.10▼$13.02Volume56 shsAverage Volume14,976 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get WuXi AppTec alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About WuXi AppTec Stock (OTCMKTS:WUXAY)WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.Read More WUXAY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WUXAY Stock News HeadlinesApril 29, 2024 | finance.yahoo.comWuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable OperationsApril 26, 2024 | americanbankingnews.comWuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Sees Large Decline in Short InterestMay 2, 2024 | Weiss Ratings (Ad)Protect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …April 15, 2024 | nytimes.comChinese Company Under Congressional Scrutiny Makes Key U.S. DrugsApril 11, 2024 | msn.comUS crackdown on China biotechnology firms causes jitters for Western clientsMarch 28, 2024 | msn.comUS Says WuXi Sends Intellectual Property to China, Reuters ReportsMarch 28, 2024 | reuters.comExclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senatorsMarch 25, 2024 | yahoo.comWuXi Bio, AppTec Jump as Biosecure Act Leader Quits CongressMay 2, 2024 | Weiss Ratings (Ad)Protect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …March 19, 2024 | finance.yahoo.comWuXi Biologics Options See Frenzy Amid US Policy UncertaintyMarch 18, 2024 | msn.comWuXi AppTec’s US Sales Rise as Congress Weighs a Federal BanMarch 15, 2024 | msn.comChina stocks close lower; Wuxi Apptec drags down Hong Kong sharesMarch 14, 2024 | msn.comCongressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech ExodusMarch 13, 2024 | ca.finance.yahoo.comBiotech trade association to split with China's WuXi AppTecMarch 12, 2024 | msn.comHong Kong Stocks: WuXi AppTec Shares Surge on Buyback NewsMarch 7, 2024 | msn.comTime to ‘cut off’ US outbound investment in China biotech firms like BGI Group and Wuxi AppTec: House panelMarch 7, 2024 | msn.comChina’s Wuxi AppTec, Biologics, tumble as US sanctions threat growsMarch 7, 2024 | msn.comWuXi Companies’ Shares Fall Amid Renewed U.S. Sanction ConcernsMarch 6, 2024 | msn.comUS Senate bill targeting China's BGI, WuXi AppTec moves forwardMarch 6, 2024 | reuters.comUS Senate committee takes up bill targeting China's BGI, WuXi ApptecMarch 6, 2024 | reuters.comUS Senate committee takes up bill targeting China's BGI, WuXi ApptecFebruary 18, 2024 | reuters.comChina's WuXi AppTec says it poses no national security risks to USJuly 19, 2023 | msn.comWuXi Biologics Hatches New Baby With ADC Drug Unit IPOJuly 10, 2023 | finance.yahoo.comAcasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH PatientsMay 26, 2023 | wsj.comWuXi AppTec Co. Ltd. ADRApril 25, 2023 | marketwatch.comWuXi AppTec Shares Slide After First-Quarter Softer Profit GrowthApril 10, 2023 | marketwatch.comPharmaceutical Testing and Analytical Services Market Insights-Industry Changing Aspects, New Technologies and Forecast to 2030See More Headlines Receive WUXAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:WUXAY CUSIPN/A CIKN/A Webwww.wuxiapptec.com Phone862120663091FaxN/AEmployees41,116Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Ge Li Ph.D. (Age 57)Co-Founder, Chairman, President & CEO Dr. Minzhang Chen Ph.D. (Age 55)Co-CEO & Executive Director Dr. Qing Yang Ph.D. (Age 55)Co-CEO & Executive Director Dr. Edward Hu M.B.A. (Age 62)Vice Chairman of the Board & Global Chief Investment Officer Ms. Ming Shi (Age 50)Senior VP & CFO Mr. Zhaohui Zhang (Age 55)COO of China, VP & Executive Director Mr. Yuanzhou Zhang (Age 36)Joint Company Secretary Mr. Ruijia TangIR DirectorDr. Howard Wu J.D.Senior VP, General Counsel & Global Head of Human ResourcesDr. Jingchao Dong Ph.D.Senior VP & Head of RCSMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors WUXAY Stock Analysis - Frequently Asked Questions How have WUXAY shares performed in 2024? WuXi AppTec's stock was trading at $10.1450 on January 1st, 2024. Since then, WUXAY shares have decreased by 55.9% and is now trading at $4.4750. View the best growth stocks for 2024 here. Are investors shorting WuXi AppTec? WuXi AppTec saw a decrease in short interest in April. As of April 15th, there was short interest totaling 3,100 shares, a decrease of 55.1% from the March 31st total of 6,900 shares. Based on an average daily trading volume, of 4,400 shares, the short-interest ratio is presently 0.7 days. View WuXi AppTec's Short Interest. How do I buy shares of WuXi AppTec? Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:WUXAY) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & CompanyAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi AppTec Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
